BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goh C, Narayanan S, Hahn YS. Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? Immunol Rev 2013;255:210-21. [PMID: 23947357 DOI: 10.1111/imr.12084] [Cited by in Crossref: 80] [Cited by in F6Publishing: 88] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Prochetto E, Borgna E, Jiménez-cortegana C, Sánchez-margalet V, Cabrera G. Myeloid-derived suppressor cells and vaccination against pathogens. Front Cell Infect Microbiol 2022;12:1003781. [DOI: 10.3389/fcimb.2022.1003781] [Reference Citation Analysis]
2 Mukherjee S, Ghosh S, Sengupta A, Sarkar S, Keswani T, Chatterjee R, Bhattacharyya A. IL-6 dependent expansion of inflammatory MDSCs (CD11b+ Gr-1+) promote Th-17 mediated immune response during experimental cerebral malaria. Cytokine 2022;155:155910. [PMID: 35594680 DOI: 10.1016/j.cyto.2022.155910] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Alvear-Arias JJ, Carrillo C, Villar JP, Garcia-Betancourt R, Peña-Pichicoi A, Fernandez A, Fernandez M, Carmona EM, Pupo A, Neely A, Alvarez O, Garate J, Barajas-Martinez H, Larsson HP, Lopez-Rodriguez A, Latorre R, Gonzalez C. Expression of Hv1 proton channels in myeloid-derived suppressor cells (MDSC) and its potential role in T cell regulation. Proc Natl Acad Sci U S A 2022;119:e2104453119. [PMID: 35377790 DOI: 10.1073/pnas.2104453119] [Reference Citation Analysis]
4 Park SJ, Nam DE, Seong HC, Hahn YS. New Discovery of Myeloid-Derived Suppressor Cell's Tale on Viral Infection and COVID-19. Front Immunol 2022;13:842535. [PMID: 35185933 DOI: 10.3389/fimmu.2022.842535] [Reference Citation Analysis]
5 Pal S, Dey D, Chakraborty BC, Nandi M, Khatun M, Banerjee S, Santra A, Ghosh R, Ahammed SM, Chowdhury A, Datta S. Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing. Hepatology 2022. [PMID: 35000202 DOI: 10.1002/hep.32331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lin EC, Chen SW, Chen LK, Lin TA, Wu YX, Juan CC, Chang YI. Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells. Front Nutr 2021;8:762363. [PMID: 34901113 DOI: 10.3389/fnut.2021.762363] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Roe K. The role of polyspecific T-cell exhaustion in severe outcomes for COVID-19 patients having latent pathogen infections such as Toxoplasmagondii. Microb Pathog 2021;161:105299. [PMID: 34813900 DOI: 10.1016/j.micpath.2021.105299] [Reference Citation Analysis]
8 Pereshein AV, Kuznetsova SV, Shevantaeva ON. On the Nonspecific Resistance in Burn Injury: Pathophysiological Aspects (Review). Sovrem Tekhnologii Med 2021;12:84-93. [PMID: 34795984 DOI: 10.17691/stm2020.12.3.11] [Reference Citation Analysis]
9 Ling Z, Yang C, Tan J, Dou C, Chen Y. Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases. Cell Mol Life Sci 2021;78:7161-83. [PMID: 34635950 DOI: 10.1007/s00018-021-03966-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Emsen A, Sumer S, Tulek B, Cizmecioglu H, Vatansev H, Goktepe MH, Kanat F, Koksal Y, Arslan U, Artac H. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19. Scand J Immunol 2021;:e13108. [PMID: 34625989 DOI: 10.1111/sji.13108] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Switzer B, Haanen J, Lorigan PC, Puzanov I, Turajlic S. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. J Immunother Cancer 2021;9:e002835. [PMID: 34272309 DOI: 10.1136/jitc-2021-002835] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Roe K. A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients. J Neurosci Res 2021. [PMID: 34288064 DOI: 10.1002/jnr.24917] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Sanaei MJ, Taheri F, Heshmati M, Bashash D, Nazmabadi R, Mohammad-Alibeigi F, Nahid-Samiei M, Shirzad H, Bagheri N. Comparing the frequency of CD33+ pSTAT3+ myeloid-derived suppressor cells and IL-17+ lymphocytes in patients with prostate cancer and benign prostatic hyperplasia. Cell Biol Int 2021. [PMID: 34184811 DOI: 10.1002/cbin.11651] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Wang Y, Wang M, Wu HX, Xu RH. Advancing to the era of cancer immunotherapy. Cancer Commun (Lond) 2021. [PMID: 34165252 DOI: 10.1002/cac2.12178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
15 Pai FT, Lu CY, Lin CH, Wang J, Huang MC, Liu CT, Song YC, Ku CL, Yen HR. Psoralea corylifolia L. Ameliorates Collagen-Induced Arthritis by Reducing Proinflammatory Cytokines and Upregulating Myeloid-Derived Suppressor Cells. Life (Basel) 2021;11:587. [PMID: 34205531 DOI: 10.3390/life11060587] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Rowlands M, Segal F, Hartl D. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19. Front Immunol 2021;12:697405. [PMID: 34220859 DOI: 10.3389/fimmu.2021.697405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sun SN, Ni SH, Li Y, Liu X, Deng JP, Chen ZX, Li H, Feng WJ, Huang YS, Li DN, Xian SX, Yang ZQ, Wang LJ, Lu L. G-MDSCs promote aging-related cardiac fibrosis by activating myofibroblasts and preventing senescence. Cell Death Dis 2021;12:594. [PMID: 34103476 DOI: 10.1038/s41419-021-03874-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Müller I, Janson L, Sauter M, Pappritz K, Linthout SV, Tschöpe C, Klingel K. Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis. Viruses 2021;13:889. [PMID: 34065891 DOI: 10.3390/v13050889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Takano T, Matsumura T, Adachi Y, Terahara K, Moriyama S, Onodera T, Nishiyama A, Kawana-Tachikawa A, Miki S, Hosoya-Nakayama K, Nakamura-Hoshi M, Seki S, Tachikawa N, Yoshimura Y, Miyata N, Horiuchi H, Sasaki H, Miyazaki K, Kinoshita N, Sudo T, Akiyama Y, Sato R, Suzuki T, Matano T, Takahashi Y. Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan. Int Immunol 2021;33:241-7. [PMID: 33538817 DOI: 10.1093/intimm/dxab005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lamsfus Calle C, Fendel R, Singh A, Richie TL, Hoffman SL, Kremsner PG, Mordmüller B. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection. Front Immunol 2021;12:625712. [PMID: 33815377 DOI: 10.3389/fimmu.2021.625712] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Liu S, Geng R, Lin E, Zhao P, Chen Y. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma. Front Genet 2021;12:602160. [PMID: 33732282 DOI: 10.3389/fgene.2021.602160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Gunasinghe SD, Peres NG, Goyette J, Gaus K. Biomechanics of T Cell Dysfunctions in Chronic Diseases. Front Immunol 2021;12:600829. [PMID: 33717081 DOI: 10.3389/fimmu.2021.600829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Safarzadeh E, Mohammadi A, Mansoori B, Duijf PHG, Hashemzadeh S, Khaze V, Kazemi T, Derakhshani A, Silvestris N, Baradaran B. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients. Front Immunol 2020;11:613215. [PMID: 33679700 DOI: 10.3389/fimmu.2020.613215] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 Quiroz-Reyes AG, Islas JF, Delgado-Gonzalez P, Franco-Villarreal H, Garza-Treviño EN. Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma. Pharmaceutics 2021;13:103. [PMID: 33466892 DOI: 10.3390/pharmaceutics13010103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sica A, Colombo MP, Trama A, Horn L, Garassino MC, Torri V. Immunometabolic Status of COVID-19 Cancer Patients. Physiol Rev 2020;100:1839-50. [PMID: 32721181 DOI: 10.1152/physrev.00018.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
26 Cervantes-Villagrana RD, Albores-García D, Cervantes-Villagrana AR, García-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther 2020;5:99. [PMID: 32555170 DOI: 10.1038/s41392-020-0205-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
27 Sanaei M, Salimzadeh L, Bagheri N. Crosstalk between myeloid‐derived suppressor cells and the immune system in prostate cancer: MDSCs and immune system in Prostate cancer. J Leukoc Biol 2019;107:43-56. [DOI: 10.1002/jlb.4ru0819-150rr] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
28 Neamah WH, Singh NP, Alghetaa H, Abdulla OA, Chatterjee S, Busbee PB, Nagarkatti M, Nagarkatti P. AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes. J Immunol 2019;203:1830-44. [PMID: 31492743 DOI: 10.4049/jimmunol.1900291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
29 Bohorquez JA, Muñoz-González S, Pérez-Simó M, Revilla C, Domínguez J, Ganges L. Identification of an Immunosuppressive Cell Population during Classical Swine Fever Virus Infection and Its Role in Viral Persistence in the Host. Viruses 2019;11:E822. [PMID: 31487968 DOI: 10.3390/v11090822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
30 Holtzhausen A, Harris W, Ubil E, Hunter DM, Zhao J, Zhang Y, Zhang D, Liu Q, Wang X, Graham DK, Frye SV, Earp HS. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma. Cancer Immunol Res 2019;7:1672-86. [PMID: 31451482 DOI: 10.1158/2326-6066.CIR-19-0008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
31 Yoshikawa FSY, Teixeira FME, Sato MN, Oliveira LMDS. Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged? Cells 2019;8:E611. [PMID: 31216738 DOI: 10.3390/cells8060611] [Cited by in Crossref: 15] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
32 Vaccari M, Fourati S, Brown DR, Silva de Castro I, Bissa M, Schifanella L, Doster MN, Foulds KE, Roederer M, Koup RA, Sui Y, Berzofsky JA, Sekaly RP, Franchini G. Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate. Front Immunol 2019;10:1072. [PMID: 31139193 DOI: 10.3389/fimmu.2019.01072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
33 Kurachi M. CD8+ T cell exhaustion. Semin Immunopathol 2019;41:327-37. [PMID: 30989321 DOI: 10.1007/s00281-019-00744-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 72] [Article Influence: 13.3] [Reference Citation Analysis]
34 Zeng Y, Li Y, Xu Z, Gan W, Lu L, Huang X, Lin C. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure. J Med Virol. 2019;91:1510-1518. [PMID: 30905084 DOI: 10.1002/jmv.25466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
35 Hirai-Yuki A, Whitmire JK, Joyce M, Tyrrell DL, Lemon SM. Murine Models of Hepatitis A Virus Infection. Cold Spring Harb Perspect Med 2019;9:a031674. [PMID: 29661811 DOI: 10.1101/cshperspect.a031674] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
36 Kumar V. Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting. Inflammation 2019;42:765-88. [DOI: 10.1007/s10753-018-0939-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
37 Scalea JR, Lee YS, Davila E, Bromberg JS. Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation. Transplantation 2018;102:359-67. [PMID: 29189485 DOI: 10.1097/TP.0000000000002022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
38 Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, Cheong HC, Yong YK, Larsson M, Shankar EM. T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses. Front Immunol 2018;9:2569. [PMID: 30473697 DOI: 10.3389/fimmu.2018.02569] [Cited by in Crossref: 127] [Cited by in F6Publishing: 151] [Article Influence: 31.8] [Reference Citation Analysis]
39 Sacchi A, Tumino N, Grassi G, Casetti R, Cimini E, Bordoni V, Ammassari A, Antinori A, Agrati C. A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry. PLoS One 2018;13:e0202920. [PMID: 30161175 DOI: 10.1371/journal.pone.0202920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
40 Salminen A, Kaarniranta K, Kauppinen A. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders. International Immunopharmacology 2018;61:231-40. [DOI: 10.1016/j.intimp.2018.06.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
41 Caruana I, Simula L, Locatelli F, Campello S. T lymphocytes against solid malignancies: winning ways to defeat tumours. Cell Stress 2018;2:200-12. [PMID: 31225487 DOI: 10.15698/cst2018.07.148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
42 Salminen A, Kauppinen A, Kaarniranta K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence. Biogerontology 2018;19:325-39. [PMID: 29959657 DOI: 10.1007/s10522-018-9762-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
43 Zöller M, Zhao K, Kutlu N, Bauer N, Provaznik J, Hackert T, Schnölzer M. Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata. Front Immunol 2018;9:1279. [PMID: 29951053 DOI: 10.3389/fimmu.2018.01279] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
44 Salminen A, Kaarniranta K, Kauppinen A. The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer’s disease. Cell Mol Life Sci 2018;75:3099-120. [DOI: 10.1007/s00018-018-2844-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
45 Özkan B, Lim H, Park SG. Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses. Int J Mol Sci 2018;19:E1468. [PMID: 29762501 DOI: 10.3390/ijms19051468] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
46 Ma X, Sheng S, Wu J, Jiang Y, Gao X, Cen X, Wu J, Wang S, Tang Y, Tang Y, Liang X. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma. Oncotarget 2017;8:42061-75. [PMID: 28159935 DOI: 10.18632/oncotarget.14939] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
47 Schönrich G, Raftery MJ. CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil". Front Immunol 2018;9:545. [PMID: 29616036 DOI: 10.3389/fimmu.2018.00545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zöller M. Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease. Front Immunol 2018;9:137. [PMID: 29456536 DOI: 10.3389/fimmu.2018.00137] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
49 Abrams SI, Netherby CS, Twum DY, Messmer MN. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions. J Interferon Cytokine Res 2016;36:442-53. [PMID: 27379866 DOI: 10.1089/jir.2015.0174] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
50 Dorhoi A, Du Plessis N. Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections. Front Immunol 2017;8:1895. [PMID: 29354120 DOI: 10.3389/fimmu.2017.01895] [Cited by in Crossref: 60] [Cited by in F6Publishing: 79] [Article Influence: 15.0] [Reference Citation Analysis]
51 Gujar S, Pol JG, Kim Y, Lee PW, Kroemer G. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies. Trends Immunol 2018;39:209-21. [PMID: 29275092 DOI: 10.1016/j.it.2017.11.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 15.2] [Reference Citation Analysis]
52 Zhou J, Nefedova Y, Lei A, Gabrilovich D. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. Semin Immunol 2018;35:19-28. [PMID: 29254756 DOI: 10.1016/j.smim.2017.12.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 142] [Article Influence: 22.2] [Reference Citation Analysis]
53 Chesney JA, Mitchell RA, Yaddanapudi K. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J Leukoc Biol 2017;102:727-40. [PMID: 28546500 DOI: 10.1189/jlb.5VMR1116-458RRR] [Cited by in Crossref: 49] [Cited by in F6Publishing: 61] [Article Influence: 9.8] [Reference Citation Analysis]
54 Tsai HF, Hsu PN. Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets. J Biomed Sci 2017;24:35. [PMID: 28545567 DOI: 10.1186/s12929-017-0341-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
55 Sui Y, Frey B, Wang Y, Billeskov R, Kulkarni S, McKinnon K, Rourke T, Fritts L, Miller CJ, Berzofsky JA. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques. PLoS Pathog 2017;13:e1006395. [PMID: 28498847 DOI: 10.1371/journal.ppat.1006395] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
56 Siwaponanan P, Siegers JY, Ghazali R, Ng T, McColl B, Ng GZ, Sutton P, Wang N, Ooi I, Thiengtavor C, Fucharoen S, Chaichompoo P, Svasti S, Wijburg O, Vadolas J. Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients. Blood 2017;129:3087-99. [PMID: 28325862 DOI: 10.1182/blood-2016-07-730135] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
57 Taleb K, Auffray C, Villefroy P, Pereira A, Hosmalin A, Gaudry M, Le Bon A. Chronic Type I IFN Is Sufficient To Promote Immunosuppression through Accumulation of Myeloid-Derived Suppressor Cells. J Immunol 2017;198:1156-63. [PMID: 28003378 DOI: 10.4049/jimmunol.1502638] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
58 Ku AW, Muhitch JB, Powers CA, Diehl M, Kim M, Fisher DT, Sharda AP, Clements VK, O'Loughlin K, Minderman H, Messmer MN, Ma J, Skitzki JJ, Steeber DA, Walcheck B, Ostrand-Rosenberg S, Abrams SI, Evans SS. Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes. Elife 2016;5:e17375. [PMID: 27929373 DOI: 10.7554/eLife.17375] [Cited by in Crossref: 41] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
59 Wei WC, Lin SY, Lan CW, Huang YC, Lin CY, Hsiao PW, Chen YR, Yang WC, Yang NS. Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis. Sci Rep 2016;6:36663. [PMID: 27857157 DOI: 10.1038/srep36663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
60 Valero-monroy O, Garcia-cervantes G, Marquez-corrales LF, Leija-montoya AG, Sandoval-basilio J, Martinez-coronilla G, Isiordia-espinoza MA, Serafin-higuera N. Myeloid derived suppressor cell: A new player in periodontal disease? Medical Hypotheses 2016;95:35-8. [DOI: 10.1016/j.mehy.2016.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Jakobshagen K, Ward B, Baschuk N, Huss S, Brunn A, Malecki M, Fiolka M, Rappl G, Corogeanu D, Karow U, Schiller P, Abken H, Heukamp LC, Deckert M, Krönke M, Utermöhlen O. Endogenous Il10 alleviates the systemic antiviral cellular immune response and T cell-mediated immunopathology in select organs of acutely LCMV-infected mice. Am J Pathol 2015;185:3025-38. [PMID: 26506472 DOI: 10.1016/j.ajpath.2015.07.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
62 Lei AH, Yang Q, Cai WP, Liu YF, Lan Y, Qin AP, Hu FY, Zhou J. Clinical Significance of Myeloid-Derived Suppressor Cells in Human Immunodeficiency Virus-1/ Hepatitis C Virus-coinfected Patients. Scand J Immunol 2016;83:438-44. [DOI: 10.1111/sji.12429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
63 Malek E, de Lima M, Letterio JJ, Kim BG, Finke JH, Driscoll JJ, Giralt SA. Myeloid-derived suppressor cells: The green light for myeloma immune escape. Blood Rev 2016;30:341-8. [PMID: 27132116 DOI: 10.1016/j.blre.2016.04.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 10.5] [Reference Citation Analysis]
64 Ost M, Singh A, Peschel A, Mehling R, Rieber N, Hartl D. Myeloid-Derived Suppressor Cells in Bacterial Infections. Front Cell Infect Microbiol 2016;6:37. [PMID: 27066459 DOI: 10.3389/fcimb.2016.00037] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 9.2] [Reference Citation Analysis]
65 Leliefeld PH, Wessels CM, Leenen LP, Koenderman L, Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Crit Care 2016;20:73. [PMID: 27005275 DOI: 10.1186/s13054-016-1250-4] [Cited by in Crossref: 127] [Cited by in F6Publishing: 138] [Article Influence: 21.2] [Reference Citation Analysis]
66 Tosello-Trampont AC, Krueger P, Narayanan S, Landes SG, Leitinger N, Hahn YS. NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice. Hepatology 2016;63:799-812. [PMID: 26662852 DOI: 10.1002/hep.28389] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
67 Horinaka A, Sakurai D, Ihara F, Makita Y, Kunii N, Motohashi S, Nakayama T, Okamoto Y. Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer. Cancer Sci 2016;107:207-16. [PMID: 26679292 DOI: 10.1111/cas.12866] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
68 Goh CC, Roggerson KM, Lee HC, Golden-Mason L, Rosen HR, Hahn YS. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1. J Immunol 2016;196:2283-92. [PMID: 26826241 DOI: 10.4049/jimmunol.1501881] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 9.5] [Reference Citation Analysis]
69 Radwan FF, Hossain A, God JM, Leaphart N, Elvington M, Nagarkatti M, Tomlinson S, Haque A. Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. J Cell Biochem 2015;116:102-14. [PMID: 25142864 DOI: 10.1002/jcb.24946] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
70 Tumino N, Turchi F, Meschi S, Lalle E, Bordoni V, Casetti R, Agrati C, Cimini E, Montesano C, Colizzi V, Martini F, Sacchi A. In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition. AIDS 2015;29:2397-407. [PMID: 26355672 DOI: 10.1097/QAD.0000000000000871] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
71 Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486-499. [PMID: 26205583 DOI: 10.1038/nri3862] [Cited by in Crossref: 1642] [Cited by in F6Publishing: 1880] [Article Influence: 234.6] [Reference Citation Analysis]
72 Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells. J Leukoc Biol 2015;98:913-22. [PMID: 26337512 DOI: 10.1189/jlb.4RI0515-204R] [Cited by in Crossref: 151] [Cited by in F6Publishing: 160] [Article Influence: 21.6] [Reference Citation Analysis]
73 O'Connor MA, Fu WW, Green KA, Green WR. Subpopulations of M-MDSCs from mice infected by an immunodeficiency-causing retrovirus and their differential suppression of T- vs B-cell responses. Virology 2015;485:263-73. [PMID: 26318248 DOI: 10.1016/j.virol.2015.07.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
74 Shah KH, Shi P, Giani JF, Janjulia T, Bernstein EA, Li Y, Zhao T, Harrison DG, Bernstein KE, Shen XZ. Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension. Circ Res 2015;117:858-69. [PMID: 26294657 DOI: 10.1161/CIRCRESAHA.115.306539] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
75 Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 2015;15:486-99. [PMID: 26205583 DOI: 10.1038/nri3862] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Clements DR, Kim Y, Gujar SA, Lee PW. All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy. Oncoimmunology 2016;5:e1057674. [PMID: 26942069 DOI: 10.1080/2162402X.2015.1057674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
77 Hock BD, Mckenzie JL, Cross NB, Currie MJ. Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study. Transplant Immunology 2015;32:164-71. [DOI: 10.1016/j.trim.2015.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
78 Kwak Y, Kim HE, Park SG. Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases. Arch Immunol Ther Exp (Warsz) 2015;63:269-85. [PMID: 25990434 DOI: 10.1007/s00005-015-0342-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
79 Ahn YH, Hong SO, Kim JH, Noh KH, Song KH, Lee YH, Jeon JH, Kim DW, Seo JH, Kim TW. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity. Clin Exp Immunol 2015;181:164-78. [PMID: 25753156 DOI: 10.1111/cei.12620] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
80 Clements DR, Sterea AM, Kim Y, Helson E, Dean CA, Nunokawa A, Coyle KM, Sharif T, Marcato P, Gujar SA, Lee PW. Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus. J Immunol 2015;194:4397-412. [PMID: 25825443 DOI: 10.4049/jimmunol.1402132] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
81 Younos IH, Abe F, Talmadge JE. Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets. Leuk Lymphoma 2015;56:2251-63. [PMID: 25407654 DOI: 10.3109/10428194.2014.987141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
82 Tebartz C, Horst SA, Sparwasser T, Huehn J, Beineke A, Peters G, Medina E. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J Immunol 2015;194:1100-11. [PMID: 25548227 DOI: 10.4049/jimmunol.1400196] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
83 Dai J, El Gazzar M, Li GY, Moorman JP, Yao ZQ. Myeloid-derived suppressor cells: paradoxical roles in infection and immunity. J Innate Immun 2015;7:116-26. [PMID: 25401944 DOI: 10.1159/000368233] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
84 Li H, Prasad R, Katiyar SK, Yusuf N, Elmets CA, Xu H. Interleukin-17 mediated inflammatory responses are required for ultraviolet radiation-induced immune suppression. Photochem Photobiol 2015;91:235-41. [PMID: 25250896 DOI: 10.1111/php.12351] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
85 Burrack KS, Morrison TE. The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front Immunol 2014;5:428. [PMID: 25250029 DOI: 10.3389/fimmu.2014.00428] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
86 Gantt S, Gervassi A, Jaspan H, Horton H. The role of myeloid-derived suppressor cells in immune ontogeny. Front Immunol 2014;5:387. [PMID: 25165466 DOI: 10.3389/fimmu.2014.00387] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
87 Yan C, Du H. Lysosomal acid lipase is critical for myeloid-derived suppressive cell differentiation, development, and homeostasis. World J Immunol 2014; 4(2): 42-51 [DOI: 10.5411/wji.v4.i2.42] [Cited by in CrossRef: 4] [Article Influence: 0.5] [Reference Citation Analysis]
88 Braciale TJ, Hahn YS. Immunity to viruses. Immunol Rev 2013;255:5-12. [PMID: 23947343 DOI: 10.1111/imr.12109] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
89 Zhang L, Zhang Z, Zhang H, Wu M, Wang Y. Myeloid-Derived Suppressor Cells Protect Mouse Models from Autoimmune Arthritis via Controlling Inflammatory Response. Inflammation 2014;37:670-7. [DOI: 10.1007/s10753-013-9783-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]